Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection.

Minghuan JiangNok-Hang LeungMargaret IpJoyce Hoi-Sze You

Published in: PloS one (2018)

In the present model, ribotype-guided FMT appears to be a potential option to save QALYs and cost when comparing with vancomycin. The cost-effectiveness of ribotype-guided FMT is subject to the patient acceptance to FMT and prevalence of ribotype 002.

Keyphrases

clostridium difficile
risk factors
early onset
case report
methicillin resistant staphylococcus aureus
cell therapy
mesenchymal stem cells
staphylococcus aureus